Frequency of blood-borne viral infections among leukemic patients in central Iraq

Saudi Medical Journal

Volumn 32, Issue 1, 2011, Pages 55-61

  Omer, Ali R ^a   Salih, Jalil I ^a   Al Nakshabandi, Abdulkader A ^b  

^a Hawler University   (Iraq)

^b UNIVERSITY OF ANBAR   (Iraq)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BLOOD SAMPLING; BLOODSTREAM INFECTION; CANCER PATIENT; CHILD; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IRAQ; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SCHOOL CHILD; SEROPREVALENCE; SEX DIFFERENCE; VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; CYTOMEGALOVIRUS INFECTIONS; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HUMANS; INFANT; IRAQ; LEUKEMIA; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; VIREMIA; YOUNG ADULT;

EID: 79951972345     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Greaves M. Infection, immune responses and the aetiology of childhood leukaemia. Nat Rev Cancer 2006; 6: 193-203.
2. Dores GM, Anderson WF, Curtis RE, Landgren O, Ostroumova E, Bluhm EC, et al. Chronic lymphocytic leukemia and small lymphocytic lymphoma: overview of the descriptive epidemiology. Br J Haematol 2007; 139: 809-819.
3. Chan Ka Wah. Acute lymphoblastic leukemia. Current Problems in Pediatric and Adolescent Health Care 2002; 32: 40-49.
4. Ministry of Health. Result of Iraqi Cancer Registry 1998-2000. Baghdad (Iraq): Iraqi Cancer Registry Center; 2002.
5. Kaur P, Basu S. Transfusion-transmitted infections: existing and emerging pathogens. Postgrad Med J 2005; 51: 146-151.
6. Niederhauser C, Mansouri Taleghani B, Graziani M, Stolz M, Tinguely C, Schneider P. Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus? Swiss Med Wkly 2008; 138: 134-141.
7. Centers for Disease Control and Prevention. Division of Viral Hepatitis, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Atlanta (GA): Centers for Disease Control and Prevention; 2008. Available from URL: http://www.allacademic.com/meta/p_mla_apa_research_citation/2/7/3/5/6/p273569_index.html
8. Rezvan H, Abolghassemi H, Kafiabad SA. Transfusiontransmitted infections among multitransfused patients in Iran: a review. Transfus Med 2007; 17: 425-433.
9. Jaffe ES, Harris NL, Stein H, Vardiman JW, editors. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon (France): IARC Press; 2001. p. 185.
10. Ministry of Health. Viral hepatitis in Iraq. Bulletin of Endemic Diseases 2002; 31: 5-9.
11. Al-Hilli JM, Ghadhban AM. Prevalence of serological marker of HB (HBsAg) and HCV (HCV Ab) among blood donors and certain risk groups in Baghdad.Journal of Faculty Medicine of Baghdad 2000; 42: 45-52.
12. Al-Jaberi AM, editor. Prevalence of HBsAg among Iraqi thalassemic patients in Thiqar province. Proceedings of the 1st Scientific Conference on Thalassemia and Haemoglobinopathies in Iraq; 2002 Jan 26-28; Baghdad, Iraq. Baghdad, Iraq: MOH; 2002.
13. Majeed MN. Prevalence of hepatitis B and hepatitis C infection among thalassemic children in Najaf City. Kufa Medical Journal 2002; 5: 192-196.
14. Mohammed DS, Jawad AM. The prevalence of viral hepatitis markers in patients with hereditary bleeding disorders. Journal of Faculty Medicine of Baghdad 2000; 42: 58-63.
15. Mustafa B, Jassim M. The prevalence of hepatitis B and C serological markers among patients with thalassaemia in Mosul. The New Iraqi Medical Journal 2009; 5: 26-30.
16. Sonmez M, Bektas O, Yilma M, Durmus A, Akdogan E, Topbas M, et al. The relation of lymphoma and hepatitis B virus /hepatitis C virus infections in the region of East Black Sea, Turkey. Tumori 2007; 93: 536-539.
17. Akimkin VG, Ledin EV, Skvortsov SV, Rukavitsyn OA. [Incidence of hepatitis B virus infection in patients with blood disease] Ter Arkh 2007; 79: 28-31. Russian.
18. Takeshita M, Sakai H, Okamura S, Oshiro Y, Higaki K, Uike N, et al. Splenic large B-cell lymphoma in patients with hepatitis C virus infection. Hum Pathol 2005; 36: 878-885.
19. Takai S, Tsurumi H, Ando k, Kasahara S, Sawada M, Yamada T, et al. Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy. Eur J Haematol 2005; 74: 158-165.
20. de Paula EV, Goucales NS, Xueref S, Addas MC, Gilli SC, Agerami RN, et al. Transfusion-transmitted infections among multi-transfused patients in Brazil. J Clin Virol 2005; 34 (Suppl 2): S27-S32.
21. Kocabas E, Aksaray N, Alhan E, Tanyeli A, Koksal F, Yarkin F. Hepatitis B and C virus infection in Turkish children with cancer. Eur J Epidemiol 1999; 13: 869-873.
22. Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006; 28: 112-125.
23. Hasan AS, Al-Dulaimi AA, Al-Dulaimi MA. The prevalence of certain blood transmitted virus infection among hemophilia and thalassemia patient in Diyala. Diala Journal 2004; 18: 157-165.
24. Abdel-Kader M, Ismail A, Tahir S. Seroprevalence of hepatitis B and C among different groups of population in Al-Tameem Province. Iraqi Journal of Community Medicine 2001; 14: 21-24.
25. Covas DT, Boturao Neto E, Zago MA. The frequency of bloodborn viral infections in a population of multitransfused Brazilian patients. Rev Inst Med Trop Sao Paulo 1993; 35: 271-273.
26. Jamal R, Fadzillah G, Zulkifli SZ, Yasmin M. Seroprevalence of hepatitis B, hepatitis C, CMV and HIV in multiply transfused thalassemia patients: results from a thalassemia day care center in Malaysia. Southeast Asian J Trop Med Public Health 1998; 29: 792-794.
27. Abdel-Wahab MF, Zakaria S, Kamel M, Abdel-Khaliq MK, Mabrouk MA, Salama H, et al. High seroprevalence of HCV among risk groups in Egypt. Am J Trop Med Hyg 1994; 51: 563-567.
28. Montella M, Crispo A, Frigeri F, Ronga D, Tridente V, De Marco M, et al. HCV and tumors correlated with immune system: a case-control study in an area of hyperendemicity. Leuk Res 2001; 25: 775-781.
29. Quinn ER, Chan CH, Hadlock KG, Foung SK, Flint M, Levy S. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 2001; 98: 3: 3745-3749.
30. Musto P. Hepatitis C virus infection and B-cell non-Hodgkin's lymphomas: more than a simple association. Clin Lymphoma 2002; 3: 150-160.
31. Bianco E, Marcucci F, Mele A, Musto P, Cotichini R, Sanpaolo MG, et al. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi- Center case-control study. Haematologica 2000; 89: 70-76.
32. Maso L, Talamini R, Montella M, Crovatto M. Hepatitis B and C viruses and Hodgkin lymphoma: A case-control study from northern and southern Italy. Haematologica 2004; 89: 70-76.
33. Murashige N, Kami M, Iwata, H, Kishi Y, Matsuo K. No relationship between HCV infection and risk of myeloid malignancy. Haematologica J 2005; 90: 572-574.
34. Jayaraman S, Chalabi Z, Perel P, Guerriero C, Roberts I. The risk of transfusion-transmitted infections in sub-Saharan Africa. Transfusion 2010; 50: 433-442.
35. Ballester JM, Rivero RA, Villaescusa R, Merlin JC, Arce AA, Castillo D, et al. Hepatitis C virus antibodies and other markers of blood-transfusion-transmitted infection in multi-transfused Cuban patients. J Clin Virol 2005; 34 (Suppl 2): S39-S46.
36. Alizi SM, Omer AR. The prevalence of cytomegalovirus infection among immunocompromised patients. Iraqi Journal of Preventive Medicine 2004; 1: 105-110.
37. Loutfy SA, Alam El-Din HM, Ibrahim MF, Hafez MM. Seroprevalence of herpes simplex virus types 1 and 2, Epstein- Barr virus, and cytomegalovirus in children with acute lymphoblastic leukemia in Egypt. Saudi Med J 2006; 27: 1139-1145.
38. Zuckerman AJ, Banatvala JE, Pattison JR, editors. Cytomegalovirus. Principles and Practice of Clinical Virology. 4th ed. London (UK): John Wiley & Sons; 2000. p. 80-112.
39. Mirmomen S, Alavian S, Hajarizadeh B, Kafaee J, Yektaparast B. Epidemiology of hepatitis B, hepatitis C and human immunodeficiency virus infections in patients with betathalassemia in Iran: a multicenter study. Archives of Iranian Medicine 2006; 9: 319-323.
40. Laguna-Torres VA, Perez-Bao J, Chauca G, Sovero M, Blichtein D, Chunga A, et al. Epidemiology of transfusion-transmitted infections among multi-transfused patients in seven hospitals in Peru. J Clin Virol 2005; 34 (Suppl 2): S61-S68.
41. Hardan A, Ismail T, Rajab A. HIV surveillance in Iraq. Bulletin of Endemic Diseases 2002; 31: 54-60.
42. Al-Khalidi SJ. A study on Epstien-Barr virus among some immunologically compromised patients [Thesis]. Baghdad (Iraq): Al-Mustansiriya University; 2006.
43. Mahjour SB, Ghaffarpasand F, Fattahi MJ, Ghaderi A, Fotouhi Ghiam A, Karimi M. Seroprevalence of human herpes simplex, hepatitis B and epstein-barr viruses in children with acute lymphoblastic leukemia in Southern Iran. Pathol Oncol Res 2010; 16: 579-582.
44. Mustafa MM, Winick NJ, Margraf LR. Epstein-Barr virus lymphoproliferative disorder in children with leukemia: case report and review of the literature. J Pediatr Hematol Oncol 1997; 19: 77-81.
45. Okan V, Yilmaz M, Bayram A, Kis C, Cifci S, Buyukhatipoglu H, et al. Prevalence of hepatitis B and C viruses in patients with lymphoproliferative disorders. Int J Hematol 2008; 88: 403-408.
46. Fiadh HM. Seroprevalence study of hepatitis C virus infection and HLA typing in Al-Ramadi City. MSc. Al-Ramadi (Iraq): Al-Anbar University; 2006.
47. Loutfy SA, Fawzy M, El-Wakil M, Moneer MM. Presence of Human Herpes Virus 6 (HHV6) in pediatric lymphomas: impact on clinical course and association with cytomegalovirus infection. Virol J 2010; 7: 287.
48. Grant S, Edmond E, Syme G. A prospective study of cytomegalovirus infection in pregnancy. I. Laboratory evidence of congenital infection following maternal primary and reactivated infection. J Infect 2001; 3: 24-31.